Literature DB >> 7230803

The role of cells and their products in the regulation of in vitro stem cell proliferation and granulocyte development.

T M Dexter, E Spooncer, D Toksoz, L G Lajtha.   

Abstract

In long-term marrow cultures haemopoiesis can be maintained in vitro for up to 6 months. Critical analysis of the cell populations produced has shown that the stem cells and their committed progeny have characteristics in common with the corresponding cell types in vivo. The maintenance of haemopoiesis in vitro is associated with the development of an appropriate inductive environment provided by bone marrow derived adherent cells. Analysis of the interactions between environmental and haemopoietic cells has been facilitated by the development of vitro systems reproducing the naturally occurring genetic environmental defects and other systems where the development of a competent inductive environment shows a dependency upon corticosteroid hormones. Investigations have shown that stem cell proliferation may be controlled by production of opposing activities, one stimulatory for DNA synthesis, the other inhibitory. A model is proposed whereby modulation in the production of these factors is determined by the physical presence of stem cells in a proposed cellular milieu, within the adherent layer. The adherent layer, apart from acting at the level of stem cell proliferation, can also modify the response of differentiating cells (eg, GM-CFC) to exogenous stimulatory activities. Addition of GM-CSF or of CSF-antiserum has no effect on haemopoiesis in long-term cultures.

Entities:  

Mesh:

Year:  1980        PMID: 7230803     DOI: 10.1002/jss.400130410

Source DB:  PubMed          Journal:  J Supramol Struct        ISSN: 0091-7419


  11 in total

1.  Differential effects of microenvironmentally presented interleukin 3 versus soluble growth factor on primitive human hematopoietic cells.

Authors:  T Otsuka; J D Thacker; C J Eaves; D E Hogge
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

2.  In vitro development of B lymphocytes from long-term cultured precursor cells.

Authors:  K A Denis; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

3.  Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers.

Authors:  H J Sutherland; P M Lansdorp; D H Henkelman; A C Eaves; C J Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

4.  Myelo-lymphopoiesis in long-term bone marrow culture.

Authors:  H G Mergenthaler
Journal:  Klin Wochenschr       Date:  1985-04-15

5.  Long-term survival of murine erythroid progenitors in long-term bone marrow culture and stromal cell culture: differentiation in peritoneal diffusion chamber culture.

Authors:  Z Ben-Ishay; G Prindull
Journal:  Blut       Date:  1989-06

6.  Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting ability.

Authors:  C L Miller; C J Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

7.  Developmentally-related changes in surface membrane glycopeptides of murine haemopoietic cells.

Authors:  J T Gallagher; A J Morris; T M Dexter
Journal:  Biochem J       Date:  1987-03-15       Impact factor: 3.857

8.  Viral infection of vascular endothelial cells alters production of colony-stimulating activity.

Authors:  S L Gerson; H M Friedman; D B Cines
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

9.  Regulation of haemopoiesis in long-term bone marrow cultures. IV. Glycosaminoglycan synthesis and the stimulation of haemopoiesis by beta-D-xylosides.

Authors:  E Spooncer; J T Gallagher; F Krizsa; T M Dexter
Journal:  J Cell Biol       Date:  1983-02       Impact factor: 10.539

10.  Fibronectin-plasma membrane interaction in the adhesion of hemopoietic cells.

Authors:  F G Giancotti; P M Comoglio; G Tarone
Journal:  J Cell Biol       Date:  1986-08       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.